YXC-001

N/A

Report date: 2026/05/27 14:14:45

Base Information

Drug NameYXC-001
Drug Alias NameYXC-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-PD-1Anti-Vascular endothelial growth factorInterleukin-2 inhibitors
TargetsProgrammed cell death protein 1Vascular endothelial growth factorInterleukin-2
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesShanghai Yizhong Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Yizhong Pharmaceutical Co Ltd +[2] 
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A